ID: ALA3144565

Max Phase: Preclinical

Molecular Formula: C44H53N7O13S

Molecular Weight: 920.01

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=O)/C=C\c1cccc(OS(=O)(=O)O)c1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C44H53N7O13S/c1-44(2,3)63-43(59)51-35(24-29-26-47-32-17-8-7-16-31(29)32)41(57)48-33(18-9-10-21-46-37(52)20-19-28-14-11-15-30(22-28)64-65(60,61)62)40(56)50-36(25-38(53)54)42(58)49-34(39(45)55)23-27-12-5-4-6-13-27/h4-8,11-17,19-20,22,26,33-36,47H,9-10,18,21,23-25H2,1-3H3,(H2,45,55)(H,46,52)(H,48,57)(H,49,58)(H,50,56)(H,51,59)(H,53,54)(H,60,61,62)/b20-19-/t33-,34-,35-,36-/m0/s1

Standard InChI Key:  KBEQIHCWGJPXMI-FQOQAYMLSA-N

Associated Targets(Human)

Cholecystokinin B receptor 3550 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cholecystokinin A receptor 976 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 920.01Molecular Weight (Monoisotopic): 919.3422AlogP: 2.44#Rotatable Bonds: 23
Polar Surface Area: 314.51Molecular Species: ACIDHBA: 11HBD: 9
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: -2.09CX Basic pKa: CX LogP: 0.45CX LogD: -2.97
Aromatic Rings: 4Heavy Atoms: 65QED Weighted: 0.03Np Likeness Score: -0.03

References

1. Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM..  (1992)  Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.,  35  (11): [PMID:1375964] [10.1021/jm00089a010]

Source